Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37385672> ?p ?o ?g. }

Showing items 1 to 100 of ±126 with 100 items per page.

Q37385672 description "article científic" @default.
Q37385672 description "article scientifique" @default.
Q37385672 description "articolo scientifico" @default.
Q37385672 description "artigo científico" @default.
Q37385672 description "artículu científicu espublizáu en 2016" @default.
Q37385672 description "bilimsel makale" @default.
Q37385672 description "scientific article published on 17 October 2016" @default.
Q37385672 description "vedecký článok" @default.
Q37385672 description "vetenskaplig artikel" @default.
Q37385672 description "videnskabelig artikel" @default.
Q37385672 description "vědecký článek" @default.
Q37385672 description "wetenschappelijk artikel" @default.
Q37385672 description "wissenschaftlicher Artikel" @default.
Q37385672 description "наукова стаття, опублікована в жовтні 2016" @default.
Q37385672 description "научни чланак" @default.
Q37385672 description "مقالة علمية نشرت في 17 أكتوبر 2016" @default.
Q37385672 name "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 name "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 name "Metronomic chemotherapy with oral vinorelbine" @default.
Q37385672 type Item @default.
Q37385672 label "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 label "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 label "Metronomic chemotherapy with oral vinorelbine" @default.
Q37385672 prefLabel "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 prefLabel "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study." @default.
Q37385672 prefLabel "Metronomic chemotherapy with oral vinorelbine" @default.
Q37385672 P1433 Q37385672-4083278C-278C-4C59-A725-5AA22B0BD51B @default.
Q37385672 P1476 Q37385672-03B8100B-5C97-40FD-97C2-8F45FC6A48A0 @default.
Q37385672 P2093 Q37385672-0976943C-95F9-427A-B2F7-D1C8E18247FC @default.
Q37385672 P2093 Q37385672-1A2B6E01-303C-4A56-8DDC-7CF4CE7F5E5A @default.
Q37385672 P2093 Q37385672-2F879C82-85F2-4F0D-89A2-4AEA83F85973 @default.
Q37385672 P2093 Q37385672-35F2EF53-6F48-4BC7-9D50-1356F18693C2 @default.
Q37385672 P2093 Q37385672-4BB3B0BB-809A-46F3-B10F-9CAC9585030C @default.
Q37385672 P2093 Q37385672-4E2C378B-0D0B-4E13-A16A-CF3AF2C96622 @default.
Q37385672 P2093 Q37385672-7A2D1D63-3F98-4CF4-AEAA-EA034BAC749F @default.
Q37385672 P2093 Q37385672-871F44D1-769D-430F-AD9B-B662E19B4DD2 @default.
Q37385672 P2093 Q37385672-8D49802E-2D84-4062-8ADD-D3F34DC22874 @default.
Q37385672 P2093 Q37385672-93DC1835-34C0-405F-A50B-8A21C5D90AE4 @default.
Q37385672 P2093 Q37385672-A0E46C39-6A46-4416-AE96-77CBF3B6D19F @default.
Q37385672 P2093 Q37385672-B4F5533B-29B5-4CA0-8A8E-C3374374A4A4 @default.
Q37385672 P2093 Q37385672-C7D2214D-6885-4709-BF9A-C557075E40E2 @default.
Q37385672 P2093 Q37385672-D05AB8DA-A97F-446F-BCCE-B80F1E21D042 @default.
Q37385672 P2093 Q37385672-DE850FA6-D4BF-483A-8638-09C290FB5D0B @default.
Q37385672 P2093 Q37385672-F9296696-F200-4AF0-8BBA-9FB980D7B343 @default.
Q37385672 P275 Q37385672-ecfb6bfa-8fd1-411f-966f-1c74130e63a6 @default.
Q37385672 P2860 Q37385672-128F1B2A-FAD3-4134-9C99-8178D62A184F @default.
Q37385672 P2860 Q37385672-1853D6BE-F5D6-435A-9CAA-57AE55491B2A @default.
Q37385672 P2860 Q37385672-545E4F48-FDD7-4B40-BF0F-AA5446033B16 @default.
Q37385672 P2860 Q37385672-5582C011-FAA8-4E1A-A8D0-D3DE398101C5 @default.
Q37385672 P2860 Q37385672-5A6EA8B4-333B-4635-9362-01CABF7CD652 @default.
Q37385672 P2860 Q37385672-6632C699-82F8-48A9-8ABD-F63D81239E65 @default.
Q37385672 P2860 Q37385672-7C4A9375-551A-4375-B32C-4BA16C3E0161 @default.
Q37385672 P2860 Q37385672-84F07A5D-AFCE-4013-B2F2-5B77EE8899A8 @default.
Q37385672 P2860 Q37385672-88DC8024-0CC8-4480-9DE1-0916C51FAB1C @default.
Q37385672 P2860 Q37385672-BC97996E-39D0-40DB-B7BE-029BE7A869D8 @default.
Q37385672 P2860 Q37385672-C10EBE34-2181-4DED-BCB5-8B8BA4145370 @default.
Q37385672 P2860 Q37385672-C47A5057-ECFF-4FB0-9A12-822E1BB44CDF @default.
Q37385672 P2860 Q37385672-CD976F58-DBBB-42A0-A584-AA96736F372D @default.
Q37385672 P2860 Q37385672-D0FDB7EE-819D-417E-A000-BA547BEDD823 @default.
Q37385672 P2860 Q37385672-F4E7F5D0-BC8A-43F3-A843-A9E2A82B4293 @default.
Q37385672 P2860 Q37385672-FE1BBDE4-F30B-46A2-A4B3-6148AF75CEC3 @default.
Q37385672 P2888 Q37385672-C6800DBA-5B35-42FB-B01A-F5E9983F5BEA @default.
Q37385672 P304 Q37385672-621FAB33-355B-4022-AD78-3EEEE22F5C1D @default.
Q37385672 P31 Q37385672-EDFDB8AB-81B0-4218-9810-6B372DD8F2D0 @default.
Q37385672 P356 Q37385672-DFD2D677-318A-4A02-8E69-4E0BF8C8B7B4 @default.
Q37385672 P407 Q37385672-52E5E76B-80A8-47C6-890E-57210FCDA38B @default.
Q37385672 P433 Q37385672-317761F2-49B4-490A-9B6D-4C1B48630592 @default.
Q37385672 P478 Q37385672-C3DB7CAF-DBC2-4B6A-B58C-20A0DAC70B3F @default.
Q37385672 P50 Q37385672-EE9CB709-BF6A-4620-AC77-EE246218112A @default.
Q37385672 P577 Q37385672-6308C663-75A9-4E31-AC4E-238BA3ADB519 @default.
Q37385672 P6216 Q37385672-6d8f2583-8f3f-49fe-8f23-7828e2f195c6 @default.
Q37385672 P698 Q37385672-A27F7546-03B7-48A9-ABF6-832976B050B6 @default.
Q37385672 P921 Q37385672-A430A50D-7AB2-4365-8770-4A90409EBFC4 @default.
Q37385672 P921 Q37385672-E27B0738-7B9A-4E54-B531-4B05D6F727D9 @default.
Q37385672 P932 Q37385672-3D972DAD-F939-463A-8CDE-A29016E45DF1 @default.
Q37385672 P356 S10549-016-4009-3 @default.
Q37385672 P698 27752847 @default.
Q37385672 P1433 Q326085 @default.
Q37385672 P1476 "Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study" @default.
Q37385672 P2093 "A Ferzi" @default.
Q37385672 P2093 "A R Gambaro" @default.
Q37385672 P2093 "C Verusio" @default.
Q37385672 P2093 "E Biraghi" @default.
Q37385672 P2093 "E Rulli" @default.
Q37385672 P2093 "F Cicchiello" @default.
Q37385672 P2093 "F Villa" @default.
Q37385672 P2093 "L Cortesi" @default.
Q37385672 P2093 "L Legramandi" @default.
Q37385672 P2093 "L Scaltriti" @default.
Q37385672 P2093 "L Zanlorenzi" @default.
Q37385672 P2093 "M Ciccarese" @default.
Q37385672 P2093 "M Giordano" @default.
Q37385672 P2093 "M Nicolini" @default.
Q37385672 P2093 "S Della Torre" @default.
Q37385672 P2093 "VICTOR Study Group" @default.
Q37385672 P275 Q20007257 @default.
Q37385672 P2860 Q27023579 @default.
Q37385672 P2860 Q33257718 @default.
Q37385672 P2860 Q36618871 @default.
Q37385672 P2860 Q37287394 @default.